ChartRow logo
ChartRow
Stocks and ETFs
REGN
Regeneron Pharmaceuticals Inc.Stock · Healthcare
$654.27+$29.55 (+4.73%)as of market close, Jul 2, 2026
CompareLLYUNHJNJABBVMRKABT

REGN trailing returns

Regeneron Pharmaceuticals Inc.'s 10-year annualized return is +6.3% per year (+84.0% cumulative). How Regeneron Pharmaceuticals Inc. (REGN) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through July 2, 2026 — cumulative and annualized, with dividends on or off.

Trailing returns by period#

To 2026-07-02. Annualized (CAGR) for windows of a year or more.

PeriodPathAnnualizedCumulative
1 day+4.7%
1 week+5.5%
1 month+8.5%
YTD-15.0%
1 year
+23.0%
+23.0%
5 years
+2.8%
+14.8%
10 years
+6.3%
+84.0%
20 years
+21.6%
+4889.6%
Since inception (1991)
+10.3%
+3022.5%

Growth of REGN#

Actual index level (solid); dashed lines are each window's constant-rate path from start to today.

5.010.020.050.01002005001,00019952000200520102015202020255 yearsJul 2021 → Jul 2026+14.8%+2.8%/year10 yearsJul 2016 → Jul 2026+84.0%+6.3%/year20 yearsJul 2006 → Jul 2026+4889.6%+21.6%/yearSince inception (1991)Apr 1991 → Jul 2026+3022.5%+10.3%/year

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-07-02). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from REGN's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum

FAQ

What is Regeneron Pharmaceuticals Inc.'s 10-year return?
Over the last 10 years, Regeneron Pharmaceuticals Inc. (REGN) returned about +6.3% a year annualized (+84.0% cumulative total return).
What is Regeneron Pharmaceuticals Inc.'s 20-year annualized return?
Over the last 20 years, Regeneron Pharmaceuticals Inc. (REGN) compounded at about +21.6% a year (+4889.6% cumulative).
What is Regeneron Pharmaceuticals Inc.'s return since inception?
Since 1991, Regeneron Pharmaceuticals Inc. (REGN) has compounded at about +10.3% a year — +3022.5% in total.